Cyclerion Therapeutics, Inc.

CYCN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$3-$13-$18-$52
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$0$0$10
Change in WC-$2-$5-$3$1
Other Non-Cash-$0-$4-$20$4
Operating Cash Flow-$4-$21-$41-$37
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$10$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$1
Investing Cash Flow$0$10$0$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$5$0$31
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$5$0$31
Forex Effect-$0$0$0$0
Net Chg. in Cash-$4-$6-$41-$4
Supplemental Information
Beg. Cash$8$13$54$58
End Cash$3$8$13$54
Free Cash Flow-$4-$21-$41-$37